Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Public ClinicalTrials.gov record NCT03630211. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Patients With Treatment Resistant Systemic Sclerosis (SSc)
Study identification
- NCT ID
- NCT03630211
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Paul Szabolcs
- Other
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Interventions
- Cyclophosphamide Drug
- Mesna Drug
- Rituximab Drug
- Alemtuzumab Drug
- Thiotepa Drug
- GM-CSF Drug
- Intravenous immunoglobulin Drug
- Total Body Irradiation Radiation
- Anti Thymocyte Globulin Drug
Drug · Radiation
Eligibility (public fields only)
- Age range
- 8 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2018
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
- Last update posted
- Oct 14, 2025
2018 – 2026
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15261 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03630211, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03630211 live on ClinicalTrials.gov.